Enzo Biochem Inc. ($0.01 Par Value) News
Enzo Biochem Blasts Higher as Revenue Jumps 62%
Enzo Biochem registered $31.5 million in sales in the latest quarter, up from $19.4 million last year, and earnings swung to a gain from a loss.
Disney, Nvidia, Walmart and 12 Other Stocks I Like for 2017's Second Half
From bank stocks to tech, these are my favorite names.
These Undervalued Stocks Are Unfairly Overlooked
David Marcus, portfolio manager for the Evermore Global Value Fund, is trying to change that perception.
Analysts' Actions -- CVS Health, Micron, Qualcomm, Pandora and More
Here are Thursday's top research calls, including upgrades for Micron, Pandora and Qualcomm, and a downgrade for CVS Health.
4 Health Care Stocks Under $10 to Watch
Keep these under-$10 health care stocks on your radar.
4 Big Volume Gainers Under $10
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
5 Stocks Poised for Breakouts
These stocks look ready to break out and trade higher from current levels.
Thursday Earnings Live Blog
Google, AMD, Enzo Biochem, JB Hunt and more report earnings today. Join our live blog to follow and comment.
Investors May See Upside Down Under
The hunger for commodities offers investment opportunities in Australia and New Zealand.
Breaking News
Billionaire Gautam Adani Loses $26 Billion in 3 Days
The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.
FTX: DOJ Seeks to Ban Bankman-Fried From Using Signal, Slack to Contact Employees
The Justice Department wants to ban Sam Bankman-Fried, the former CEO of bankrupt FTX, from speaking to former employees of the crypto exchange.
Elon Musk Has Questions About the War in Ukraine
The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.
A Royal Caribbean Cruise Line Adult Favorite Has Not Come Back
The cruise line has almost fully returned to normal after the covid pandemic, but one very popular activity hasn't been brought back.